<prompt> Please answer with one of the option in the bracket. Write reasoning in between . Write answer in between .Q:A 30-year-old woman with a 1-year history of medically-managed Graves disease visits her endocrinologist to discuss her desire to become pregnant and whether pregnancy is safe with her medications. Her temperature is 98.4F 36.9C, blood pressure is 11066 mmHg, pulse is 78min, respirations are 12min. The endocrinologist advises that the patient may pursue pregnancy, but first needs to be switched to a new medication for her Graves disease. Which of the following is a possible side effect in this new medication that is not a risk in her old medication?? A: Agranulocytosis, B: Aplastic anemia, C: Fulminant hepatic necrosis, D: Skin rash, E: Thyroid storm,  <response>: This is a clinical vignette about a 30-year-old woman with Graves disease who wants to become pregnant. She is currently on antithyroid medications to manage her Graves disease. The endocrinologist advises switching her to a new medication before pursuing pregnancy. The question asks about a possible side effect of the new medication that is not a risk with her current medication. To answer this, I need to consider the antithyroid medications used to treat Graves disease and their side effect profiles. The most common medications are methimazolecarbimazole and propylthiouracil PTU. Methimazolecarbimazole can rarely cause agranulocytosis and aplastic anemia. PTU is more likely to cause fulminant hepatic necrosis. Rash and thyroid storm are risks with both medications.C: Fulminant hepatic necrosis 